Bam?
That hospital alone ran a SR-aGvHD trial with results expected to be published in November this year, and managed to recruit 45 patients with SR-aGvHD in a timeframe of 3.5 years. That is almost one patient per month with SR-aGvHD (not HR-aGvHD like our P2 trial). That's about the same rate as CYP's P1 trial with 7 (!) hospitals. This one hospital in Lithuania.
Don't believe me? Feel free to check it out yourself:
https://www.isrctn.com/ISRCTN18091201?q=&filters=conditionCategory:Injury%5C,%20Occupational%20Diseases%5C,%20Poisoning,trialStatus:Ongoing,publicationStatus:withoutResults&sort=relevance&offset=4&totalResults=56&page=1&pageSize=10&searchType=basic-search
Bam indeed.
Bam?That hospital alone ran a SR-aGvHD trial with results...
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $39.74M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.5¢ | 22.0¢ | $29.06K | 131.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 951 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 15.59pm 08/11/2024 (20 minute delay) ? |
| CYP (ASX) Chart |